730 filings
Page 3 of 37
8-K
54ivxj6d7srzdzfy
9 Nov 22
Armata Pharmaceuticals Announces Third Quarter 2022 Results and Provides Corporate Update
4:11pm
8-K
4krwhm
20 Sep 22
Results of Operations and Financial Condition
5:23pm
8-K
lorr4
11 Aug 22
Armata Pharmaceuticals Announces Second Quarter 2022 Results and Provides Corporate Update
4:10pm
EFFECT
b0hvcldg14yoxgji
1 Jun 22
Notice of effectiveness
12:15am
424B3
j5lim6obw
31 May 22
Prospectus supplement
6:49pm
CORRESP
xqedae5fkp oqohz5
26 May 22
Correspondence with SEC
12:00am
UPLOAD
v95ia
19 May 22
Letter from SEC
12:00am
EFFECT
e3n9cx9g6koy
7 Apr 22
Notice of effectiveness
12:15am
424B3
hdf1rgz1qa22e
6 Apr 22
Prospectus supplement
4:50pm
CORRESP
zqg4fsn04kr2tx
5 Apr 22
Correspondence with SEC
12:00am
UPLOAD
674p p5b0g0
1 Apr 22
Letter from SEC
12:00am
8-K
wpc1s321qkuw1
31 Mar 22
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of
4:05pm
8-K
ewk9 iluqbrmcgwvn
28 Mar 22
Departure of Directors or Certain Officers
5:08pm